Circle defends its hands-off approach to freezing funds as critics point to hundreds of millions in losses tied to delayed action.Finance, Circle, Stablecoins, NewsRead More

You might also be interested in reading J&J suing Samsung Bioepis over Stelara biosimilar: report.